Literature DB >> 35442860

Neurovascular Complications and Pulmonary Arteriovenous Malformation Feeding Artery Size.

Theodora Ananiadis1, Marie E Faughnan2, Dewi Clark2, Vikram Prabhudesai2, Helen Kim3, Michael T Lawton4, Nicholas T Vozoris2,5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35442860      PMCID： PMC9353961          DOI： 10.1513/AnnalsATS.202202-130RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  10 in total

Review 1.  Pulmonary arteriovenous malformations. A state of the art review.

Authors:  J R Gossage; G Kanj
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

2.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

3.  Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.

Authors:  C L Shovlin; J E Jackson; K B Bamford; I H Jenkins; A R Benjamin; H Ramadan; E Kulinskaya
Journal:  Thorax       Date:  2007-11-02       Impact factor: 9.139

4.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

Review 5.  The pulmonary vascular complications of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; J T Granton; L H Young
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

Review 6.  Pulmonary vascular complications of hereditary haemorrhagic telangiectasia.

Authors:  Sebastian Circo; James R Gossage
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 7.  Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).

Authors:  Vincent Cottin; Sophie Dupuis-Girod; Gaetan Lesca; Jean-François Cordier
Journal:  Respiration       Date:  2007       Impact factor: 3.580

8.  Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.

Authors:  Amy L Akers; Karen L Ball; Marianne Clancy; Anne M Comi; Marie E Faughnan; Rashmi Gopal-Srivastava; Thomas P Jacobs; Helen Kim; Jeffrey Krischer; Douglas A Marchuk; Charles E McCulloch; Leslie Morrison; Marsha Moses; Claudia S Moy; Ludmilla Pawlikowska; William L Young
Journal:  J Rare Disord       Date:  2013-04-01

9.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; V A Palda; G Garcia-Tsao; U W Geisthoff; J McDonald; D D Proctor; J Spears; D H Brown; E Buscarini; M S Chesnutt; V Cottin; A Ganguly; J R Gossage; A E Guttmacher; R H Hyland; S J Kennedy; J Korzenik; J J Mager; A P Ozanne; J F Piccirillo; D Picus; H Plauchu; M E M Porteous; R E Pyeritz; D A Ross; C Sabba; K Swanson; P Terry; M C Wallace; C J J Westermann; R I White; L H Young; R Zarrabeitia
Journal:  J Med Genet       Date:  2009-06-23       Impact factor: 6.318

10.  A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study.

Authors:  Paola Pierucci; Gennaro M Lenato; Patrizia Suppressa; Patrizia Lastella; Vincenzo Triggiani; Raffaella Valerio; Mario Comelli; Daniela Salvante; Alessandro Stella; Nicoletta Resta; Giancarlo Logroscino; Francesco Resta; Carlo Sabbà
Journal:  Orphanet J Rare Dis       Date:  2012-06-07       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.